| 000 | 01685 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250512012638.0 | ||
| 264 | 0 | _c19890802 | |
| 008 | 198908s 0 0 eng d | ||
| 022 | _a0002-9149 | ||
| 024 | 7 |
_a10.1016/0002-9149(89)90924-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBassand, J P | |
| 245 | 0 | 0 |
_aLimitation of myocardial infarct size and preservation of left ventricular function by early administration of APSAC in myocardial infarction. _h[electronic resource] |
| 260 |
_bThe American journal of cardiology _cJul 1989 |
||
| 300 |
_a18A-23A; discussion 24A-26A p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAnistreplase |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHeart _xphysiopathology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMulticenter Studies as Topic |
| 650 | 0 | 4 |
_aMyocardial Infarction _xdrug therapy |
| 650 | 0 | 4 |
_aPlasminogen _xadministration & dosage |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aStreptokinase _xadministration & dosage |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aVascular Patency _xdrug effects |
| 700 | 1 | _aMachecourt, J | |
| 700 | 1 | _aCassagnes, J | |
| 700 | 1 | _aLusson, J R | |
| 700 | 1 | _aBorel, E | |
| 700 | 1 | _aSchiele, F | |
| 773 | 0 |
_tThe American journal of cardiology _gvol. 64 _gno. 2 _gp. 18A-23A; discussion 24A-26A |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0002-9149(89)90924-7 _zAvailable from publisher's website |
| 999 |
_c2668632 _d2668632 |
||